OraSure Technologies(OSUR)
Search documents
Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc
Gurufocus· 2024-10-04 20:03
Overview of the Recent Transaction On September 30, 2024, Neuberger Berman Group LI.C, a prominent investment firm, made a significant addition to in investment portfolio by aequiring 3,927,692 shares of OraSure Technologies Inc (OSUR, Financial). This transaction, executed at a price of $4.27 per share, marks a notable increase in the firm's holdings in the medical devices sector. The trade reflects an 8.73% change in the firm's previous stake, emphasizing a strategic move to bolster its position in OraSur ...
OraSure Technologies Elects Jack Kenny to the Board of Directors
GlobeNewswire News Room· 2024-09-09 11:05
BETHLEHEM, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024. With the addition of Mr. Kenny, OraSure's Board of Directors currently has seven members. Mr. Kenny is the former Chief Executive Officer for Meridian Bioscience, where he led the company's turnaround before it was acquired. He has mor ...
OraSure Technologies(OSUR) - 2024 Q2 - Earnings Call Transcript
2024-08-07 01:04
OraSure Technologies Inc (NASDAQ:OSUR) Q2 2024 Results Conference Call August 6, 2024 5:00 PM ET Company Participants Jason Plagman - Vice President-Investor Relations Carrie Eglinton Manner - President and Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Andrew Cooper - Raymond Jones Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies Incorporated 2024 Second Quarter Earnings Conference Call. At this time, ...
OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates
ZACKS· 2024-08-06 23:27
OraSure Technologies (OSUR) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 133.33%. A quarter ago, it was expected that this diagnostic test maker would post earnings of $0.04 per share when it actually produced earnings of $0.04, delivering no surprise. Over the last four quarters, the ...
OraSure Technologies(OSUR) - 2024 Q2 - Quarterly Report
2024-08-06 21:10
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q ______________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to _________ . Commission File Number 001-16537 _____ ...
OraSure Technologies(OSUR) - 2024 Q2 - Quarterly Results
2024-08-06 20:08
| --- | --- | |--------------------------|-------| | | | | Investor Contact: | | | Jason Plagman | | | VP, Investor Relations | | | investorinfo@orasure.com | | Corporate Communications media@orasure.com | --- | |----------------| | | | | | | | Media Contact: | | | | Amy Koch | | Director, | | | OraSure Reports Q2 '24 Revenue of $54.3 Million Q2 GAAP EPS of $(0.01); Q2 Non-GAAP EPS of $0.07 OraQuick® HCV Self-test is the first globally to earn WHO pre-qualification Strong momentum with Syphilis Health Check ...
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
GlobeNewswire News Room· 2024-07-22 20:05
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024. A webcast of the conference call will be available on the investor relations page of OraSure's website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 ...
OraSure Technologies Supports National HIV Testing Day
GlobeNewswire News Room· 2024-06-27 11:05
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Testing Day, held each year on June 27th. These testing initiatives will help encourage thousands of people across the U.S. to get tested for HIV. According to the Centers for Disease Control & Prevention, it is estima ...
OraSure Technologies Supports National HIV Testing Day
Newsfilter· 2024-06-27 11:05
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Testing Day, held each year on June 27th. These testing initiatives will help encourage thousands of people across the U.S. to get tested for HIV. "Testing is critical to stemming the spread of HIV and our OraQuick® HI ...
OraSure Technologies(OSUR) - 2024 Q1 - Quarterly Report
2024-05-09 20:18
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ Delaware 36-4370966 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-Q ______________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024. For the transition period from _________to _________ . Commission File N ...